Creso Pharma to acquire ImpACTIVE in a shares exchange transaction

SYDNEY, AUSTRALIA: Creso Pharma Limited has entered into an asset purchase agreement to acquire the ImpACTIVE through a newly incorporated Creso subsidiary, Creso ImpACTIVE Ltd. This allows Creso Pharma to significantly strengthen its North American footprint and leading range of CBD products. Under the Agreement, Creso Pharma will acquire the ImpACTIVE Assets for C$200,000 payable…